IsoPSA Case Study: Active Surveillance


Presented by:
Aaron Berger, MD
Chief Medical Officer​
Director, Clinical Research​
Associated Urological Specialists, Solaris Health

Patient Information

Age: 63 years old
Condition: Gleason 6 Prostate Cancer
Family History of PCa: Yes

Other Details:

2022

  • PSA 7.2 (March)
  • mpMRI: PI-RADS 2 and volume 37cc
  • Systematic biopsy showed 3/12 cores GG1 prostate cancer
  • PSA 7.4 (November)

2023

  • PSA 7.5 (May)
  • mpMRI - PI-RADS 3 lesion
  • Confirmatory biopsy again shows GG1 disease
  • PSA 8.7 (November)
 

 More Like This:

 
 

If you’d like to learn more about how IsoPSA can be incorporated into your practice, please contact us here.